Literature DB >> 15244444

Morphology of elastic poly(L-lactide-co-epsilon-caprolactone) copolymers and in vitro and in vivo degradation behavior of their scaffolds.

Sung In Jeong1, Byung-Soo Kim, Young Moo Lee, Kyo Jin Ihn, Soo Hyun Kim, Young Ha Kim.   

Abstract

Very elastic PLCL [poly(L-lactide-co-epsilon-caprolactone), 50:50] copolymers were synthesized and extruded into porous tubular scaffolds (pore size 150 +/- 50 microm, porosity 90%) for the application to tissue engineering. The copolymers were basically random and amorphous. However, two T(g)'s (glass transition temperatures) were observed in dynamic mechanical thermal analysis and also in differential scanning calorimetry thermograms. Furthermore, microdomains (about 17 nm in size) were indicated on the small-angle X-ray scattering profile and finally confirmed by transmission electron microscopy. Therefore, the PLCL copolymer was probably composed of a soft matrix of mainly epsilon-caprolactone moieties and hard domains containing more L-lactide units to exhibit a rubberlike elasticity in virtue of the physically cross-linked structure. The smooth muscle cells seeded scaffolds were implanted into nude mice subcutaneously for up to 15 weeks to monitor the in vivo degradation. In addition, they were degraded in vitro in phosphate buffer solution (pH 7.4) for up to 1 year to compare the results each other. All the scaffolds degraded slowly in vivo and in vitro even in the form of a highly porous thin membrane. However, the degradation rate was somewhat faster for in vivo than for in vitro. This should be explained by enzymes that might have played a certain role in the degradation in the body. In addition, the epsilon-caprolactone moieties degraded faster than the L-lactide units did in these PLCL scaffolds, although their hydrophilicities are in the opposite order. This behavior appeared more prominently in the in vivo case. This should result from that the amorphous regions composed of mainly epsilon-caprolactone units might have been first attacked by water because water can penetrate into the amorphous regions easier than the hard domains containing more L-lactides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15244444     DOI: 10.1021/bm049921i

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  16 in total

1.  Functional lactide monomers: methodology and polymerization.

Authors:  Warren W Gerhardt; David E Noga; Kenneth I Hardcastle; Andrés J García; David M Collard; Marcus Weck
Journal:  Biomacromolecules       Date:  2006-06       Impact factor: 6.988

2.  Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.

Authors:  Stella E Aniagyei; Lee B Sims; Danial A Malik; Kevin M Tyo; Keegan C Curry; Woihwan Kim; Daniel A Hodge; Jinghua Duan; Jill M Steinbach-Rankins
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-11-10       Impact factor: 7.328

3.  Micropattern-based nerve guidance conduit with hundreds of microchannels and stem cell recruitment for nerve regeneration.

Authors:  DoYeun Park; Donghak Kim; Su Jeong Park; Jeong Ho Choi; Yoojin Seo; Dong-Hwee Kim; Sang-Hoon Lee; Jung Keun Hyun; Jin Yoo; Youngmee Jung; Soo Hyun Kim
Journal:  NPJ Regen Med       Date:  2022-10-20

4.  The effect of Substance P/Heparin conjugated PLCL polymer coating of bioinert ePTFE vascular grafts on the recruitment of both ECs and SMCs for accelerated regeneration.

Authors:  Donghak Kim; Justin J Chung; Youngmee Jung; Soo Hyun Kim
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 5.  Regenerative and engineered options for urethroplasty.

Authors:  Filippo Pederzoli; Gregory Joice; Andrea Salonia; Trinity J Bivalacqua; Nikolai A Sopko
Journal:  Nat Rev Urol       Date:  2019-06-06       Impact factor: 14.432

6.  Kinetic degradation and biocompatibility evaluation of polycaprolactone-based biologics delivery matrices for regenerative engineering of the rotator cuff.

Authors:  Anupama Prabhath; Varadraj N Vernekar; Vignesh Vasu; Mary Badon; Jean-Emmanuel Avochinou; Alexandru D Asandei; Sangamesh G Kumbar; Eckhard Weber; Cato T Laurencin
Journal:  J Biomed Mater Res A       Date:  2021-05-11       Impact factor: 4.396

Review 7.  Tissue engineering of urinary bladder and urethra: advances from bench to patients.

Authors:  Hazem Orabi; Sara Bouhout; Amélie Morissette; Alexandre Rousseau; Stéphane Chabaud; Stéphane Bolduc
Journal:  ScientificWorldJournal       Date:  2013-12-24

8.  Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis.

Authors:  Niina Ahola; Minna Veiranto; Noora Männistö; Matti Karp; Jaana Rich; Alexander Efimov; Jukka Seppälä; Minna Kellomäki
Journal:  Biomatter       Date:  2012 Oct-Dec

9.  An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.

Authors:  Niina Ahola; Noora Männistö; Minna Veiranto; Matti Karp; Jaana Rich; Alexander Efimov; Jukka Seppälä; Minna Kellomäki
Journal:  Biomatter       Date:  2013-01-01

10.  Is the poly (L- lactide- co- caprolactone) nanofibrous membrane suitable for urinary bladder regeneration?

Authors:  Marta Pokrywczynska; Arkadiusz Jundzill; Jan Adamowicz; Tomasz Kowalczyk; Karolina Warda; Marta Rasmus; Lukasz Buchholz; Sandra Krzyzanowska; Pawel Nakielski; Tomasz Chmielewski; Magdalena Bodnar; Andrzej Marszalek; Robert Debski; Malgorzata Frontczak-Baniewicz; Grzegorz Mikułowski; Maciej Nowacki; Tomasz A Kowalewski; Tomasz Drewa
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.